MP
Maxona Pharmaceuticals, Inc.
SEC filingPharmaceuticals · Malvern, PA
Amount raised$5.8Msold at filing
Total offering$12M$6.2M still open
Investors in the raise56count reported to the SEC
FiledAug 14, 2026first sale Jun 4, 2025
Form D does not name the investors. If a news report names them, they appear here.
Named in the filing
Richard BrandExecutive Officer
Behshad SheldonDirector
Shahin FatholahiExecutive Officer, Director
David NakamuraDirector
Executive officers, directors and promoters as listed on the Form D.